Normunity
Latest round
- Series B
Last raised
- Jan 2025
Total raised
- $140M
Investors
- 12
About Normunity
a. Normunity is a biotech company that develops a new class of precision immuno-oncology medicines that target novel mechanisms that free the body’s normal immunity against cancer. n January 2025, Normunity Inc. The company provides a pipeline of immune normalizers that can restore the immune system’s intrinsic activity to identify and eliminate cancer cells. Normunity is also developing immunotherapies that will be precision cancer medicines developed with companion diagnostics for treating cancer as monotherapy and in combinations. The firm’s lead program is a monoclonal antibody that targets a secreted enzyme that is highly upregulated in multiple human cancers and drives the exclusion of T-cell infiltration in immuno-sensitive tumors. In addition, Normunity is advancing additional immune normalizer programs that target other mechanisms of immune cell exclusion and other mechanisms outside the tumor microenvironment that attenuate immune function.
Who invested in Normunity
12 investors across 2 rounds
See all investors in Normunity
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Normunity
Who invested in Normunity?
Normunity has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Normunity raised?
Normunity has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Normunity last raise money?
Normunity's most recent round on record is a Series B, in Jan 2025.
What does Normunity do?
Normunity is a biotechnology company.
Where is Normunity headquartered?
Normunity is headquartered in West Haven, US.
Which VCs invest in companies like Normunity?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Normunity's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Normunity? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.